Subscribe to Newsletter

Bio-Techne

ACD - a Bio-Techne brand, shortens the path to personalized medicine and enables research, drug development and clinical applications by unlocking the power of RNA. ACD is a leader in the emerging field of molecular pathology, developing cell- and tissue-based research and diagnostic tests for personalized medicine. ACD’s products and pharma assay services are based on its proprietary RNAscope® technology, the first multiplex fluorescent and chromogenic in situ hybridization platform, capable of detecting and quantifying single molecules of RNA in situ.

Bio-Techne
19 Barton Lane
Abingdon Science Park
Abingdon
OX14 3NB
United Kingdon
Phone: +44 1235 529449
[email protected]

Content by Bio-Techne:

Diagnostics Histology

One Slide, All the Answers

| Sponsored by Bio-Techne

An innovative RNA in situ hybridization technology both localizes and quantifies RNA biomarkers to provide comprehensive diagnostic information

Superior Determination of HPV using RNAscope™ In Situ Hybridization

| Contributed by Bio-Techne

HPV has been identified as a causal agent in oropharyngeal squamous cell carcinoma (OPSCC).

RNAscope CE-IVD Detection

| Contributed by Bio-Techne

RNAscope identifies RNA expression patterns and localization at the single-cell level with spatial and morphologic context.

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register